Hereditary Hemorrhagic Telangiectasia

Kamal, Arif Hossain; Prakash, Udaya B. S.
November 2007
Mayo Clinic Proceedings;Nov2007, Vol. 82 Issue 11, p1364
Academic Journal
The article describes the condition of a patient with hereditary hemorrhagic telangiectasia. Hereditary hemorrhagic telangiectasia is an autosomal dominant condition characterized by telangiectasias and bleeding. Treatment consists of prevention and control of hemorrhage from telangiectasia and arteriovenous malformation.


Related Articles

  • Hereditary Hemorrhagic Telangiectasia Causing High Output Cardiac Failure: Treatment With Transcatheter Embolization. Trotter, James F.; Suhocki, Paul V.; Lina, John R.; Martin, Lawrence W.; Parrish, Joseph L.; Swantkowski, Thomas // American Journal of Gastroenterology;Sep1998, Vol. 93 Issue 9, p1569 

    We report a case of hereditary hemorrhagic telangiectasia complicated by high output heart failure caused by intrahepatic arteriovenous malformations. This patient was treated using transcatheter embolization of the intrahepatic arteriovenous malformations with concurrent measurement of cardiac...

  • Otorhinolaryngological manifestations of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu... Yanagisawa, Ken; Yanagisawa, Eiji // ENT: Ear, Nose & Throat Journal;Jun1996, Vol. 75 Issue 6, p336 

    Discusses two cases of hereditary hemorrhagic teleangiectasia (HHT) or Osler-Weber-Rendu disease, a bleeding disorder transmitted as an automosomal dominant disease affecting both sexes equally. Epistaxis; Treatment; Diagnosis and symptoms; Sites of hemorrhage.

  • Tumors From Stem Cells.  // JAMA: Journal of the American Medical Association;3/18/2009, Vol. 301 Issue 11, p1118 

    The article reports on the case of an Israeli boy with ataxia telangiectasia, a disease which is usually fatal in the second or third decade and causes degeneration of certain brain regions and impaired immunity. A discussion of repeated injections of fetal neural stem cells which were given to...

  • Hereditary hemorrhagic telangiectasia patients can tolerate anticoagulation. Edwards, Christine; Shehata, Nadine; Faughnan, Marie // Annals of Hematology;Dec2012, Vol. 91 Issue 12, p1959 

    Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by arteriovenous malformations (AVMs) and hemorrhage. HHT patients can also suffer from unrelated medical conditions requiring anticoagulant or antiplatelet treatment (collectively 'AT'), though...

  • Cancer incidence in patients with hereditary hemorrhagic telangiectasia. Duarte, Christine; Black, Adam; Lucas, F.; Vary, Calvin // Journal of Cancer Research & Clinical Oncology;Feb2017, Vol. 143 Issue 2, p209 

    Purpose: Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder characterized by deficiency in endoglin, an angiogenic protein. We previously showed that HHT, in which systemic endoglin expression is reduced, was associated with better survival outcomes in cancer patients (Duarte et...

  • Hereditary hemorrhagic telangiectasia in Japanese patients. Komiyama, Masaki; Ishiguro, Tomoya; Yamada, Osamu; Morisaki, Hiroko; Morisaki, Takayuki // Journal of Human Genetics;Jan2014, Vol. 59 Issue 1, p37 

    To describe clinical presentations of hereditary hemorrhagic telangiectasia (HHT) patients in Japan. There were 80 patients (40 men and 40 women, age 2-78, mean 39.4 years old), who were either genetically verified or genetically not identifiable but clinically definite HHT patients. Clinical...

  • A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. Cole, S. G.; Begbie, M. E.; Wallace, G. M. F.; Shovlin, C. L. // Journal of Medical Genetics;Jul2005, Vol. 42 Issue 7, p577 

    Patients with hereditary haemorrhagic telangiectasia (HI-IT, or Osler-Weber-Rendu syndrome) have variable presentation patterns and a high risk of preventable complications. Diagnostic tests for mutations in endoglin (HF-IT type 1) and ALK-1 {HHT type 2) are available. Some HHT patients are now...

  • Antworten zu «Hereditäre hämorrhagische Teleangiektasie (Osler-Rendu-Syndrom) » aus PRAXIS Nr. 2.  // Praxis (16618157);1/30/2013, Vol. 102 Issue 3, p177 

    No abstract available.

  • Functional and splicing defect analysis of 23 ACVRL1 mutations in a cohort of patients affected by Hereditary Hemorrhagic Telangiectasia. Alaa el Din, Ferdos; Patri, Sylvie; Thoreau, Vincent; Rodriguez-Ballesteros, Montserrat; Hamade, Eva; Bailly, Sabine; Gilbert-Dussardier, Brigitte; Abou Merhi, Raghida; Kitzis, Alain // PLoS ONE;7/15/2015, Vol. 10 Issue 7, p1 

    Hereditary Hemorrhagic Telangiectasia syndrome (HHT) or Rendu-Osler-Weber (ROW) syndrome is an autosomal dominant vascular disorder. Two most common forms of HHT, HHT1 and HHT2, have been linked to mutations in the endoglin (ENG) and activin receptor-like kinase 1 (ACVRL1or ALK1) genes...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics